What You Should Know:
Today, Vytalize Health announced it has acquired Independent Physician Association (“IPA”) of New York, one of the nation's largest IPAs with more than 3,000 providers. Financial details of the acquisition were not disclosed.The deal scales Vytalize's successful value-based care model to new payer arrangements and specialty care across the healthcare spectrum.Based in Suffolk County, IPA NY is one of the largest multi-specialty
Read More
Ocutrx Acquires Spectrum AMT to Advance Capabilities for Medical Devices
What You Should Know:
Ocutrx Technologies, a global technology company developing medical devices with augmented reality (AR), extended reality (XR) and artificial intelligence (AI), acquires Spectrum Advanced Manufacturing Technologies, Inc., a Colorado-based electronics manufacturing and assembly company.With this acquisition, the consolidated Oxutrx_Spectrum company now has seven (7) process lines, including ISO Optics Lab capabilities,
Read More
Oshi Health Raises $30M for Virtual Multidisciplinary Digestive Care
What You Should Know:
- Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics raises $30M in Series B funding led by Koch Disruptive Technologies (KDT) and joined by existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures.
- Oshi Health is currently available to over 20 million people as a preferred in-network virtual gastroenterology clinic for
Read More
MedArrive Secures $8M to Expand At-Home Care
What You Should Know:
- MedArrive, a Mobile-integrated care management platform company today announced $8M in new funding led by Cobalt Ventures, a wholly owned subsidiary of Blue Cross and Blue Shield of Kansas City (Blue KC). The investment follows MedArrive’s $25 million series A round in November 2021 and brings the company’s total funding to $40.5M to date
- MedArrive plans to use the new investment to expand its payer relationships, build out its team and
Read More
Exec Hires: COTA Appoints First Chief Commercial Officer
What You Should Know:
- COTA, Inc., an oncology real-world data and analytics company, today announced the appointment of Sandy Leonard as its first Chief Commercial Officer.
- As CCO, Sandy will drive COTA’s life sciences growth strategy, prioritizing customer success and experience. More specifically, she will lead a team that is laser-focused on ensuring that pharmaceutical partners have the data assets, analytics, services, and support they need to develop life-saving
Read More
Audio-Only Telehealth Remains Common at Safety Net Clinics, Study Finds
What You Should Know:
Audio-only telehealth visits for both primary care and mental health services remained common at safety net clinics in California since the start of the COVID-19 pandemic, according to a new RAND Corporation study.
The RAND study published in the Journal of the American Medical Association found that in August 2022 audio-only visits still accounted for 1 in 5 primary care visits and 2 in 5 behavioral health visits among people who received care at Federally
Read More
Availity Acquires Olive AI’s Utilization Management Solution and Business Unit
What You Should Know:
- Availity today announced a definitive agreement to acquire the utilization management solution and business unit from healthcare automation company Olive AI, Inc. Financial details of the acquisition were not disclosed.
- The acquisition of Olive AI's utilization management solution offers numerous benefits for Availity’s national network of payers and providers. These include lower administrative and medical costs, improved patient access
Read More
Clearday and Viveon Health Merge to Create Longevity Care Company
What You Should Know:
- Clearday, an innovative longevity technology company using an integrated platform of robotic companion care and AI-driven technology to serve the senior adult care sector, and Viveon Health Acquisition Corp., a special purpose acquisition (SPAC) company have entered into a definitive merger agreement.
- The combined company's pro forma equity valuation (assuming no share redemptions) is expected to be approximately $370M. VHAQ currently has $20M held in a trust
Read More
Biostage Raises $6M to Advance Clinical Trials
What You Should Know:
Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock.The funds will be used to accelerate the clinical development of Biostage’s lead product candidate, the Biostage Esophageal Implant, or BEI. The FDA has approved a
Read More
HeartFlow Raises $215M for AI-Powered Cardiac Test
What You Should Know:
- HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management.
- HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary
Read More
